Press release
Gastrointestinal Therapeutics Market Size to Reach $52.41 Billion by 2029 | Growth at 5.5% CAGR Forecast
Gastrointestinal Therapeutics
What is the Projected Market Size of the Gastrointestinal Therapeutics Industry?
There has been significant expansion in the market size of gastrointestinal therapeutics in the past few years. The market value is expected to escalate from $39.99 billion in 2024 to $42.30 billion in 2025, witnessing a compound annual growth rate (CAGR) of 5.8%. Factors contributing to the growth in the historical period include increased government spending on healthcare, a growth in early detection rates, heightened public awareness of gut health, a rise in digestive disorders related to lifestyle, and the augmentation of multidisciplinary treatment strategies.
What Will Be the Size of the Gastrointestinal Therapeutics Market by 2029?
It is anticipated that the market size for gastrointestinal therapeutics will experience considerable expansion in the coming years. The market will elevate to $52.41 billion by 2029, with a compound annual growth rate (CAGR) of 5.5%. The projected growth during this forecast period is a result of increased demand for biologics and targeted treatments, growing acceptance of personalized medicine, patient propensity towards combination therapies, heightened focus on microbiome-oriented therapeutics, and an increase in gastrointestinal complications associated with antibiotics. The main trends for this forecasted period involve the incorporation of technology in endoscopy devices, the development of microbiome-focused therapies, digital health and remote monitoring integration, multi-omics data incorporation in therapeutic development, and innovations in acid suppression treatments.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-therapeutics-global-market-report
What Are the Key Drivers Accelerating Growth in the Gastrointestinal Therapeutics Market?
The growth of the gastrointestinal therapeutics market is anticipated to be driven by the increasing prevalence of inflammatory bowel diseases (IBD). IBD, including primary conditions like Crohn's disease and ulcerative colitis, is a chronic disease that incites inflammation in the digestive tract. A combination of genetic predisposition leading to an abnormal immune response to gut microbes contributes to the increase of these diseases. Gastrointestinal therapeutics are employed to control and treat these bowel diseases by targeting the root inflammation, modulating digestive functions, and relieving related symptoms, thereby enhancing patient outcomes. To exemplify, data from the IBD Registry, a non-profit organization based in the UK, revealed that in December 2023, over 5,300 individuals were registered with IBD, a surge of more than 3,000 members compared to 2022. Consequently, the upsurge in inflammatory bowel diseases is contributing to the expansion of the gastrointestinal therapeutics market.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25768&type=smp
How Is the Gastrointestinal Therapeutics Market Segmented by Type, Application, and Region?
The gastrointestinal therapeutics market covered in this report is segmented -
1) By Product: Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics
2) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration
3) By Application: Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Over-The-Counter Gastrointestinal Therapeutics: Antacids, Laxatives, Anti-Diarrheal Agents, Digestive Enzymes, Probiotics, H2-Receptor Antagonists, Simethicone Products
2) By Prescription-Based Gastrointestinal Therapeutics: Proton Pump Inhibitors, Antibiotics For H. pylori, Aminosalicylates, Biologics, Corticosteroids, Immunosuppressants, Antiemetics
What Are the Key Trends Driving Growth in the Gastrointestinal Therapeutics Market?
Leading firms in the gastrointestinal therapeutics market are prioritizing the development of novel therapies like sustained-release (SR) fixed-dose combination capsules. These advancements are expected to boost treatment efficiency and patient adherence. These SR fixed-dose combination capsules are orally administered medicines that progressively release various active compounds to sustain steady drug concentrations and minimize dosage frequency. In 2024, Akums Drugs and Pharmaceuticals Limited, a pharmaceutical preparation manufacturing company in India, introduced rabeprazole + levosulpiride SR capsules into the Indian market for the treatment of gastrointestinal disorders. The formulation merges rabeprazole, a proton pump suppressant known to reduce stomach acidity, with levosulpiride, a prokinetic compound that enhances gut movement. In unison, these components effectively alleviate issues such as heartburn, acid reflux, bloating, and indigestion. This combination is commonly recommended for the management of gastroesophageal reflux disease, peptic ulcers, and various other associated gastrointestinal (GI) disorders.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25768&type=smp
Who Are the Leading Companies Driving Growth in the Gastrointestinal Therapeutics Market?
Major companies operating in the gastrointestinal therapeutics market are Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, Olympus Corporation, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy's Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation
Which Is the Leading Region in the Global Gastrointestinal Therapeutics Market?
North America was the largest region in the gastrointestinal therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Speak With Our Expert: Saumya Sahay: Americas +1 310-496-7795: Asia +44 7882 955267 & +91 8897263534: Europe +44 7882 955267: Email: saumyas@tbrc.info: The Business Research Company - www.thebusinessresearchcompany.com: Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastrointestinal Therapeutics Market Size to Reach $52.41 Billion by 2029 | Growth at 5.5% CAGR Forecast here
News-ID: 4157143 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Gastrointestinal
The Rising Prevalence Of Gastrointestinal Diseases And Its Impact On The Gastroi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Gastrointestinal Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the market size of gastrointestinal devices has expanded significantly. The growth is set to continue, increasing from $11.11 billion in 2024 to $11.7 billion in 2025, which equates to a…
Prominent Gastrointestinal Pathogen Testing Market Trend for 2025: Advancements …
What combination of drivers is leading to accelerated growth in the gastrointestinal pathogen testing market?
The rise in foodborne diseases is expected to drive the growth of the gastrointestinal pathogen testing market. Foodborne diseases, caused by consuming contaminated food or drinks, are on the rise due to changes in food production and distribution, inadequate food safety measures, and climate change. Gastrointestinal pathogen testing helps identify pathogens responsible for foodborne illnesses, aiding…
Major Market Shift in Gastrointestinal Pathogen Testing Industry: Advancements I …
What Is the Forecasted Market Size and Growth Rate for the Gastrointestinal Pathogen Testing Market?
The market size for gastrointestinal pathogen testing has seen a consistent growth lately. Projected to surge from $4.05 billion in 2024 to $4.24 billion in 2025, it is expected to grow at a compound annual growth rate (CAGR) of 4.6%. The growth observed during the historic period can be ascribed to factors such as the amplified…
Gastrointestinal Bleeding Treatment Devices Market Report 2024 - Gastrointestina …
"The Business Research Company recently released a comprehensive report on the Global Gastrointestinal Bleeding Treatment Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free…
Gastrointestinal (GI) Stents Market is Driven by Rising Prevalence of Gastroint …
The Gastrointestinal (GI) Stents Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
View Report - https://www.theinsightpartners.com/reports/gastrointestinal-gi-stents-market/
Gastrointestinal stents are used as an effective alternate to perform…
Gastrointestinal Devices Market Report 2018: Segmentation by Type (Gastrointesti …
Global Gastrointestinal Devices market research report provides company profile for Coloplast, Given Imaging, CONMED, Covidien, Ethicon, Olympus, Boston Scientific and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
